UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on September 8, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $117.76 ($1,118,720) on September 8, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 40 Common Stock at $481.91 ($19,276) on September 8, 2026; holds 333,903 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $483.90 ($96,780) on September 8, 2026; holds 333,703 after (Indirect).
- Open-market sale: disposed of 220 Common Stock at $491.04 ($108,028) on September 8, 2026; holds 333,483 after (Indirect).
- Open-market sale: disposed of 140 Common Stock at $492.72 ($68,980) on September 8, 2026; holds 333,343 after (Indirect).
- Open-market sale: disposed of 144 Common Stock at $493.98 ($71,133) on September 8, 2026; holds 333,199 after (Indirect).
- Open-market sale: disposed of 600 Common Stock at $494.87 ($296,923) on September 8, 2026; holds 332,599 after (Indirect).
- Open-market sale: disposed of 256 Common Stock at $495.75 ($126,912) on September 8, 2026; holds 332,343 after (Indirect).
- Open-market sale: disposed of 300 Common Stock at $497.05 ($149,115) on September 8, 2026; holds 332,043 after (Indirect).
- Open-market sale: disposed of 1,902 Common Stock at $498.18 ($947,531) on September 8, 2026; holds 330,141 after (Indirect).
- Open-market sale: disposed of 1,018 Common Stock at $498.77 ($507,746) on September 8, 2026; holds 329,123 after (Indirect).
- Open-market sale: disposed of 1,173 Common Stock at $500.20 ($586,734) on September 8, 2026; holds 327,950 after (Indirect).
- Open-market sale: disposed of 1,221 Common Stock at $501.17 ($611,934) on September 8, 2026; holds 326,729 after (Indirect).
- Open-market sale: disposed of 1,167 Common Stock at $502.26 ($586,135) on September 8, 2026; holds 325,562 after (Indirect).
- Open-market sale: disposed of 701 Common Stock at $503.33 ($352,833) on September 8, 2026; holds 324,861 after (Indirect).
- Open-market sale: disposed of 418 Common Stock at $504.15 ($210,733) on September 8, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on September 8, 2026; holds 480,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,740,795 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Common Stock | 9,500 | $118 | $1.1M | 333,943 |
| 2026-09-08 | Open-market sale | Common Stock | 40 | $482 | $19.3K | 333,903 |
| 2026-09-08 | Open-market sale | Common Stock | 200 | $484 | $96.8K | 333,703 |
| 2026-09-08 | Open-market sale | Common Stock | 220 | $491 | $108.0K | 333,483 |
| 2026-09-08 | Open-market sale | Common Stock | 140 | $493 | $69.0K | 333,343 |
| 2026-09-08 | Open-market sale | Common Stock | 144 | $494 | $71.1K | 333,199 |
| 2026-09-08 | Open-market sale | Common Stock | 600 | $495 | $296.9K | 332,599 |
| 2026-09-08 | Open-market sale | Common Stock | 256 | $496 | $126.9K | 332,343 |
| 2026-09-08 | Open-market sale | Common Stock | 300 | $497 | $149.1K | 332,043 |
| 2026-09-08 | Open-market sale | Common Stock | 1,902 | $498 | $947.5K | 330,141 |
| 2026-09-08 | Open-market sale | Common Stock | 1,018 | $499 | $507.7K | 329,123 |
| 2026-09-08 | Open-market sale | Common Stock | 1,173 | $500 | $586.7K | 327,950 |
| 2026-09-08 | Open-market sale | Common Stock | 1,221 | $501 | $611.9K | 326,729 |
| 2026-09-08 | Open-market sale | Common Stock | 1,167 | $502 | $586.1K | 325,562 |
| 2026-09-08 | Open-market sale | Common Stock | 701 | $503 | $352.8K | 324,861 |
| 2026-09-08 | Open-market sale | Common Stock | 418 | $504 | $210.7K | 324,443 |
| 2026-09-08 | Option exercise/conversion | Stock Option | 9,500 | — | — | 480,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (9,500 shares) |
| 2026-09-08 | Open-market sale (40 shares) |
| 2026-09-08 | Open-market sale (200 shares) |
| 2026-09-08 | Open-market sale (220 shares) |
| 2026-09-08 | Open-market sale (140 shares) |
| 2026-09-08 | Open-market sale (144 shares) |
| 2026-09-08 | Open-market sale (600 shares) |
| 2026-09-08 | Open-market sale (256 shares) |
| 2026-09-08 | Open-market sale (300 shares) |
| 2026-09-08 | Open-market sale (1,902 shares) |
| 2026-09-08 | Open-market sale (1,018 shares) |
| 2026-09-08 | Open-market sale (1,173 shares) |
| 2026-09-08 | Open-market sale (1,221 shares) |
| 2026-09-08 | Open-market sale (1,167 shares) |
| 2026-09-08 | Open-market sale (701 shares) |
| 2026-09-08 | Open-market sale (418 shares) |
| 2026-09-08 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.